2 top blue chip ASX 200 shares rated as buys

Looking for blue chips? Check out these highly rated shares…

| More on:
woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you wanting to buy some blue chip ASX shares for your portfolio? Then you might want to check out the ones listed below.

These quality companies have been tipped as blue chips to buy. Here's what you need to know:

ResMed Inc. (ASX: RMD)

The first blue chip for investors to consider is ResMed. It is a medical device company with a focus on sleep disorders.

ResMed has continued to grow at a decent rate over the last 12 months despite the pandemic's negative impact on sleep disorder diagnoses and referrals. The good news is that with vaccines rolling out, referrals are expected to pick up again in FY 2022. And with one of its largest rivals recently having to recall an extremely popular sleep apnoea device, the company has been tipped to win further market share and continue its growth.

Looking further ahead, the company still has a very long runway for growth over the next decade. In fact, management has set itself a goal of improving 250 million lives in out-of-hospital healthcare in 2025. Helping it achieve this goal will be its high quality product portfolio, rapidly growing digital health ecosystem, and the growing awareness of sleep disorders and their impact on a person's overall health.

Earlier today, Macquarie upgraded the company's shares to an outperform rating with a $34.85 price target.

Sonic Healthcare Limited (ASX: SHL)

A second blue chip share to look at is Sonic Healthcare. It is a leading medical diagnostics company with operations across the world.

Unlike ResMed, Sonic has had the wind in its sails over the last 12 months. This led to the company reporting a 33% increase in half year revenue to $4.4 billion and a 166% jump in first half net profit to $678 million in February.

This was driven largely by strong demand for COVID-19 testing services. However, it is worth acknowledging that the rest of the business has been performing positively as well since trading conditions returned to relatively normal.

One broker that is a fan of the company is Credit Suisse. It currently has an outperform rating and $40.00 price target on Sonic's shares.

The broker is seeing signs of pent up demand for healthcare services after people delayed seeking healthcare during the pandemic. It expects Sonic to benefit from this, along with further COVID-19 testing in the near term.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

Blue chip in a trolley with a man pushing it.
Opinions

3 ASX 200 blue-chip shares to buy today: experts

Looking for investment inspiration among the ASX 200 large-cap stocks?

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Investing Strategies

A blue-chip ASX share poised to benefit from falling interest rates

A leading ASX blue chip is building a massive pipeline of data centre and logistics projects, positioning itself to benefit…

Read more »

Person holding a blue chip.
Blue Chip Shares

Why 14 analysts are bullish on this ASX blue-chip share

Experts are widely bullish on the prospects of this stock.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

2 strong ASX blue-chip shares rated as buys by this top fund manager

These businesses have a lot going for them.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

2 of the best ASX 200 blue chip shares to buy in August

Let's see which blue chips Bell Potter is bullish on.

Read more »

Person holding a blue chip.
Blue Chip Shares

4 ASX 200 blue-chip shares to hold but not buy: experts

These blue-chips are worth holding if you already own them, but are too expensive for new investors to buy.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Blue Chip Shares

2 strong blue chip ASX 200 shares to buy with $20,000

Let's see why analysts think these top stocks could be buys.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Blue Chip Shares

Should you buy, hold, or sell CBA, Fortescue, and Woolworths shares?

One broker has given its verdict on these blue chips.

Read more »